期刊文献+

大剂量甲基强的松龙联用硫酸镁注射液治疗重症哮喘的疗效 被引量:6

Effect of Large Dose of Methylprednisone Combined with Magnesium Sulfate Injection on Severe Asthma
下载PDF
导出
摘要 目的探讨大剂量甲基强的松龙联合硫酸镁注射液治疗重症哮喘的临床效果。方法将60例重症哮喘的患者随机分为对照组和观察组,每组30例,对照组采用甲基强的松龙治疗,观察组在对照组治疗的基础上加用25%硫酸镁注射液治疗,比较2组治疗的临床疗效及治疗前后最大呼气流量(PEF)、用力肺活量(FVC)、1s用力呼气容量(FEV1)的变化。结果对照组和观察组的总有效率分别为63.3%和93.3%,观察组优于对照组(P<0.05);2组治疗前后PEF、FVC以及FEV1差异均具有统计学意义(P<0.05),观察组治疗后与对照组治疗后比较差异也具有统计学意义(P<0.05)。结论大剂量甲基强的松龙联合硫酸镁注射液治疗重症哮喘可迅速有效地控制哮喘症状,且无明显不良反应发生,临床效果满意。 Objective To observe the clinical effect of large dose of methylprednisone combined with magnesium sulfate injection on severe asthma. Methods Sixty patients with severe asthma were randomly assigned to receive either methylprednisone (control group,n= 30) or in combina- tion with 25 % magnesium sulfate injection (observation group,n=30). One-second forced expira- tory volume (FEV1),forced vital capacity (FVC) and peak expiratory flow (PEF) were deter- mined before and after treatment. The clinical effects were compared between the two groups. Re- sults The total effective rate in control group was significantly lower than that in observation group (63.3% vs 93.3% ,P〈0.05). The values of PEF,FVC and FEV1 were obviously different between the two groups before and after treatment (P〈0.05). Moreover, these spirometric val- ues significantly changed after treatment in both groups(P〈0. 05). Conclusion Large dose of methylprednisone combined with magnesium sulfate injection can quickly and effectively control asthma symptoms and does not produce adverse reactions.
出处 《实用临床医学(江西)》 CAS 2012年第3期17-18,21,共3页 Practical Clinical Medicine
关键词 甲基强的松龙 硫酸镁注射液 重症哮喘 methylprednisone magnesium sulfate injeetion severe asthma
  • 相关文献

参考文献4

二级参考文献33

  • 1丁敏娇,戴元荣.糖皮质激素防治支气管哮喘患者气道重塑的研究进展[J].中华结核和呼吸杂志,2005,28(9):656-658. 被引量:19
  • 2郭胤仕,许以平,徐艳华.粉尘螨抗原对支气管哮喘患者外周血单个核细胞T-bet和GATA3及FOXP3 mRNA表达水平的影响[J].中华结核和呼吸杂志,2007,30(2):112-115. 被引量:3
  • 3中华结核和呼吸杂志编辑委员会.支气管哮喘的定义、诊断、严重度分级及疗效判断标准[J].中华结核和呼吸杂志,1993,16:5-5.
  • 4Corbridge TC,Hall JB.Assesment and mangment of adults with status asthmaticus[J].Am J Respir Crit Care Med,1995,151:1302-1311.
  • 5Schleimer RP.Allergy principles and practice[M].New York:C.V.Mosby,1992,130:1767-1772.
  • 6杨锡强.儿科学,2003.
  • 7Umetsu DT;Akbari O;Dekruyff RH.Regulatory T cells control the development of allergic disease and asthma[J],2003(03).
  • 8Berthelot JM;Maugars Y.Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis).Facts and hypotheses[J],2004(05).
  • 9Noguchi E;Shibasaki M;Kamioka M.New polymorphisms of haematopoietic prostaglandin D synthase and human prostanoid DP receptor genes[J],2002(01).
  • 10Tachibana A;Kimura H;kato M.Respiratory syncytial virus enhances the expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor[J],2002(01).

共引文献40

同被引文献37

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部